PL345574A1 - Angiogenesis inhibitors - Google Patents
Angiogenesis inhibitorsInfo
- Publication number
- PL345574A1 PL345574A1 PL99345574A PL34557499A PL345574A1 PL 345574 A1 PL345574 A1 PL 345574A1 PL 99345574 A PL99345574 A PL 99345574A PL 34557499 A PL34557499 A PL 34557499A PL 345574 A1 PL345574 A1 PL 345574A1
- Authority
- PL
- Poland
- Prior art keywords
- angiogenesis inhibitors
- angiogenesis
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11088598A | 1998-07-06 | 1998-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL345574A1 true PL345574A1 (en) | 2001-12-17 |
Family
ID=22335452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99345574A PL345574A1 (en) | 1998-07-06 | 1999-07-06 | Angiogenesis inhibitors |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1094812A4 (de) |
JP (1) | JP2002519377A (de) |
KR (1) | KR20010079497A (de) |
CN (1) | CN1308534A (de) |
AU (1) | AU4862599A (de) |
BR (1) | BR9911885A (de) |
CA (1) | CA2336774A1 (de) |
HU (1) | HUP0104509A3 (de) |
ID (1) | ID28125A (de) |
NO (1) | NO20010085L (de) |
PL (1) | PL345574A1 (de) |
SK (1) | SK242001A3 (de) |
WO (1) | WO2000001383A1 (de) |
ZA (1) | ZA200007405B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
ATE375330T1 (de) | 2000-04-17 | 2007-10-15 | Ucb Pharma Sa | Enamin-derivate als zell-adhäsionsmoleküle |
US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
AU2003212558A1 (en) | 2002-03-20 | 2003-09-29 | Koninklijke Philips Electronics N.V. | Active matrix electroluminescent display devices, and their manufacture |
US8586033B2 (en) * | 2003-12-03 | 2013-11-19 | The Scripps Research Institute | Integrin αIIbβ3 specific antibodies and peptides |
WO2017090157A1 (ja) * | 2015-11-26 | 2017-06-01 | 大和薬品株式会社 | 血管新生抑制剤 |
CN109535035A (zh) * | 2019-01-08 | 2019-03-29 | 吉尔生化(上海)有限公司 | 一种n-苄氧羰基-3-氨基-丙氨酸叔丁酯的制备方法 |
CN113773260B (zh) * | 2021-08-26 | 2023-09-22 | 华南师范大学 | 一种类共价有机材料及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0664792B1 (de) * | 1992-10-14 | 2000-01-05 | Merck & Co. Inc. | Fibrinogenrezeptor-antagonisten |
JPH08504194A (ja) * | 1992-12-01 | 1996-05-07 | メルク エンド カンパニー インコーポレーテッド | フィブリノーゲンレセプターアンタゴニスト |
AU701776B2 (en) * | 1994-05-27 | 1999-02-04 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
JP2000508319A (ja) * | 1996-04-10 | 2000-07-04 | メルク エンド カンパニー インコーポレーテッド | αvβ3拮抗薬 |
-
1999
- 1999-07-06 ID IDW20010172A patent/ID28125A/id unknown
- 1999-07-06 BR BR9911885-8A patent/BR9911885A/pt not_active Application Discontinuation
- 1999-07-06 WO PCT/US1999/015252 patent/WO2000001383A1/en not_active Application Discontinuation
- 1999-07-06 HU HU0104509A patent/HUP0104509A3/hu unknown
- 1999-07-06 EP EP99932289A patent/EP1094812A4/de not_active Withdrawn
- 1999-07-06 CN CN99808280A patent/CN1308534A/zh active Pending
- 1999-07-06 CA CA002336774A patent/CA2336774A1/en not_active Abandoned
- 1999-07-06 PL PL99345574A patent/PL345574A1/xx not_active Application Discontinuation
- 1999-07-06 AU AU48625/99A patent/AU4862599A/en not_active Abandoned
- 1999-07-06 SK SK24-2001A patent/SK242001A3/sk unknown
- 1999-07-06 JP JP2000557829A patent/JP2002519377A/ja active Pending
- 1999-07-06 KR KR1020017000144A patent/KR20010079497A/ko not_active Application Discontinuation
-
2000
- 2000-12-12 ZA ZA200007405A patent/ZA200007405B/xx unknown
-
2001
- 2001-01-05 NO NO20010085A patent/NO20010085L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200007405B (en) | 2001-09-21 |
AU4862599A (en) | 2000-01-24 |
EP1094812A1 (de) | 2001-05-02 |
NO20010085D0 (no) | 2001-01-05 |
BR9911885A (pt) | 2001-03-27 |
EP1094812A4 (de) | 2003-04-16 |
ID28125A (id) | 2001-05-03 |
WO2000001383A1 (en) | 2000-01-13 |
KR20010079497A (ko) | 2001-08-22 |
CA2336774A1 (en) | 2000-01-13 |
NO20010085L (no) | 2001-03-05 |
CN1308534A (zh) | 2001-08-15 |
JP2002519377A (ja) | 2002-07-02 |
HUP0104509A3 (en) | 2002-05-28 |
HUP0104509A2 (hu) | 2002-04-29 |
SK242001A3 (en) | 2001-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1109555A4 (de) | Neue angiogeneseinhibitoren | |
EP1097147A4 (de) | Neue angiogenese-inhibitoren | |
EP0984692A4 (de) | Angiogenese-inhibitoren | |
EP1017682A4 (de) | Neue angiogenese-inhibitoren | |
GB9900416D0 (en) | Inhibitors | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
HUP0202076A3 (en) | Triazine angiogenesis inhibitors | |
PL345574A1 (en) | Angiogenesis inhibitors | |
EP1153022A4 (de) | Protease inhibitoren | |
GB9821993D0 (en) | Centraliser | |
GB9816729D0 (en) | Substituted cyclohexylaminopyrimidines | |
HK1039937A1 (zh) | 取代的3-硫代氨基甲酰基吡唑類化合物 | |
PL347397A1 (en) | Substituted 3-aryl-pyrazoles | |
GB2389113B (en) | B-secretase inhibitor | |
EP1025851A4 (de) | alpha-GLUCOSIDASE HEMMER | |
HUP0102476A3 (en) | Substituted cyclooctadepsipeptides | |
HK1039335A1 (zh) | 取代的苯甲酰基環已二酮類化合物 | |
GB9822700D0 (en) | Novel angiogenesis inhibitors | |
GB9810544D0 (en) | Novel angiogenesis inhibitors | |
GB9800681D0 (en) | Novel angiogenesis inhibitors | |
EP1354589A4 (de) | Angiogenese-hemmer | |
GB9803416D0 (en) | Inhibitors | |
GB9826992D0 (en) | Inhibitors | |
GB9828697D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |